Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Infectious Disease

HIV/Immunodeficiency

A high mucosal blocking score is associated with HIV protection

AIDS | Feb 04, 2019 HIV/Immunodeficiency

Cardiac dysfunction among people living with HIV: A systematic review and meta-analysis

JACC: Heart Failure | Feb 01, 2019 HIV/Immunodeficiency

Prevalence of hepatitis B virus, hepatitis C virus, and HIV infection among patients with newly diagnosed cancer from academic and community oncology practices

JAMA | Jan 22, 2019 HIV/Immunodeficiency

Cancer disparities in people with human immunodeficiency virus: A systematic review of screening for non-AIDS–defining malignancies

Cancer | Jan 20, 2019 HIV/Immunodeficiency

Medical intensive care unit admission among patients with and without HIV, hepatitis C virus, and alcohol-related diagnoses in the United States: A national, retrospective cohort study, 1997–2014

Journal of Acquired Immune Deficiency Syndromes | Jan 20, 2019 HIV/Immunodeficiency

Monocyte-to-lymphocyte ratio is associated with tuberculosis disease and declines with anti-TB treatment in HIV-infected children

Journal of Acquired Immune Deficiency Syndromes | Jan 19, 2019 HIV/Immunodeficiency

Associations between cannabis use, sexual behavior, and sexually transmitted infections/human immunodeficiency virus in a cohort of young men who have sex with men

Sexually Transmitted Diseases | Jan 18, 2019 HIV/Immunodeficiency

Heart failure and adverse heart failure outcomes among persons living with HIV in a US tertiary medical center

American Heart Journal | Jan 17, 2019 HIV/Immunodeficiency

Dolutegravir plus lamivudine vs dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): Week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

The Lancet | Jan 12, 2019 HIV/Immunodeficiency

Safety of elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in HIV-1-infected adults with end-stage renal disease on chronic haemodialysis: An open-label, single-arm, multicentre, phase 3b trial

The Lancet HIV | Jan 11, 2019 HIV/Immunodeficiency

« Prev 1 … 72 73 74 75 76 … 113 Next »

A high mucosal blocking score is associated with HIV protection

Cardiac dysfunction among people living with HIV: A systematic review and meta-analysis

Prevalence of hepatitis B virus, hepatitis C virus, and HIV infection among patients with newly diagnosed cancer from academic and community oncology practices

Cancer disparities in people with human immunodeficiency virus: A systematic review of screening for non-AIDS–defining malignancies

Medical intensive care unit admission among patients with and without HIV, hepatitis C virus, and alcohol-related diagnoses in the United States: A national, retrospective cohort study, 1997–2014

Monocyte-to-lymphocyte ratio is associated with tuberculosis disease and declines with anti-TB treatment in HIV-infected children

Associations between cannabis use, sexual behavior, and sexually transmitted infections/human immunodeficiency virus in a cohort of young men who have sex with men

Heart failure and adverse heart failure outcomes among persons living with HIV in a US tertiary medical center

Dolutegravir plus lamivudine vs dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): Week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

Safety of elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in HIV-1-infected adults with end-stage renal disease on chronic haemodialysis: An open-label, single-arm, multicentre, phase 3b trial

Article on Hypertension in CKD Patients: Management Updates

Artice: Adult Vaccination Updates Every Family Doctor Should Know

MD Clip on Diabetes and Urinary ACR with Dr Saraogi

Article: TSH Abnormalities and Treatment Algorithms in Primary Care

New research aims to transform treatments of aggressive blood cancer

A high mucosal blocking score is associated with HIV protection

Cardiac dysfunction among people living with HIV: A systematic review and meta-analysis

Prevalence of hepatitis B virus, hepatitis C virus, and HIV infection among patients with newly diagnosed cancer from academic and community oncology practices

Cancer disparities in people with human immunodeficiency virus: A systematic review of screening for non-AIDS–defining malignancies

Medical intensive care unit admission among patients with and without HIV, hepatitis C virus, and alcohol-related diagnoses in the United States: A national, retrospective cohort study, 1997–2014

Monocyte-to-lymphocyte ratio is associated with tuberculosis disease and declines with anti-TB treatment in HIV-infected children

Associations between cannabis use, sexual behavior, and sexually transmitted infections/human immunodeficiency virus in a cohort of young men who have sex with men

Heart failure and adverse heart failure outcomes among persons living with HIV in a US tertiary medical center

Dolutegravir plus lamivudine vs dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): Week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

Safety of elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in HIV-1-infected adults with end-stage renal disease on chronic haemodialysis: An open-label, single-arm, multicentre, phase 3b trial

Article on Hypertension in CKD Patients: Management Updates

Artice: Adult Vaccination Updates Every Family Doctor Should Know

MD Clip on Diabetes and Urinary ACR with Dr Saraogi

Article: TSH Abnormalities and Treatment Algorithms in Primary Care

New research aims to transform treatments of aggressive blood cancer

Select Specialty

Select Topic